Apolipoprotein B Secretion Is Regulated by Hepatic Triglyceride, and Not Insulin, in a Model of Increased Hepatic Insulin Signaling-Reference-Cited by-同舟云学术

Apolipoprotein B Secretion Is Regulated by Hepatic Triglyceride, and Not Insulin, in a Model of Increased Hepatic Insulin Signaling

Published:2012-02 Issue:2 Volume:32 Page:236-246
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Moon Byoung C.¹,Hernandez-Ono Antonio¹,Stiles Bangyan¹,Wu Hong¹,Ginsberg Henry N.¹

Affiliation:

1. From the Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY (B.C.M., A.H.-O., H.N.G.); Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA (B.S.); Department of Molecular and Medical Pharmacology (H.W.) and Institute for Molecular Medicine (H.W.), David Geffen School of Medicine, University of California, Los Angeles, CA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference63 articles.

1. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion

2. Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance

3. The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism

4. Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes

5. Role of insulin in lipoprotein secretion by cultured rat hepatocytes.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes;Atherosclerosis;2024-07

2. Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis;Frontiers in Oncology;2022-10-05

3. Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response;Biomedicine & Pharmacotherapy;2022-08

4. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease;Canadian Journal of Gastroenterology and Hepatology;2022-05-11

5. Discovery of analogues of non-β oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism;Nutrition, Metabolism and Cardiovascular Diseases;2021-07